WordNet
- a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
- a gastrointestinal hormone produced by epithelial cells lining the fundus of the stomach; appears to be a stimulant for appetite and feeding, but is also a strong stimulant of growth hormone secretion from the anterior pituitary
PrepTutorEJDIC
- =sense organ / 受信装置
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/10/18 14:20:27」(JST)
[Wiki en表示]
Growth hormone secretagogue receptor |
Identifiers |
Symbol |
GHSR |
External IDs |
OMIM: 601898 MGI: 2441906 HomoloGene: 57161 IUPHAR: ghrelin receptor ChEMBL: 4616 GeneCards: GHSR Gene |
Gene Ontology |
Molecular function |
• growth hormone secretagogue receptor activity
• G-protein coupled receptor activity
• growth hormone-releasing hormone receptor activity
• peptide hormone binding
|
Cellular component |
• plasma membrane
• cell surface
• integral to membrane
• neuron projection
• membrane raft
|
Biological process |
• G-protein coupled receptor signaling pathway
• actin polymerization or depolymerization
• adult feeding behavior
• response to hormone stimulus
• hormone-mediated signaling pathway
• growth hormone secretion
• response to food
• positive regulation of appetite
• negative regulation of interleukin-1 beta production
• cellular response to insulin stimulus
• positive regulation of multicellular organism growth
• negative regulation of tumor necrosis factor biosynthetic process
• regulation of hindgut contraction
• positive regulation of insulin-like growth factor receptor signaling pathway
• negative regulation of interleukin-6 biosynthetic process
• positive regulation of fatty acid metabolic process
• negative regulation of insulin secretion
• decidualization
• negative regulation of inflammatory response
• regulation of synapse assembly
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
2693 |
208188 |
|
Ensembl |
ENSG00000121853 |
ENSMUSG00000051136 |
|
UniProt |
Q92847 |
Q99P50 |
|
RefSeq (mRNA) |
NM_004122 |
NM_177330 |
|
RefSeq (protein) |
NP_004113 |
NP_796304 |
|
Location (UCSC) |
Chr 3:
172.16 – 172.17 Mb |
Chr 3:
27.37 – 27.38 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Growth hormone secretagogue receptor is a G protein-coupled receptor that binds ghrelin[1] and plays a role in energy homeostasis and regulation of body weight.[2]
Contents
- 1 Function
- 2 Transcripts
- 3 Selective ligands
- 3.1 Agonists
- 3.2 Antagonists
- 4 References
- 5 Further reading
- 6 External links
Function[edit]
Ghrelin is an appetite-regulating factor secreted from peripheral organs that is involved in regulation of energy homoeostasis via binding to the receptor resulting in the secretion of growth hormone by the pituitary gland. [3] The pathway activated by binding of ghrelin to the growth hormone secretagogue receptor, GHSR1a, regulates the activation of the downstream mitogen-activated protein kinase, Akt, nitric oxide synthase, and AMPK cascades in different cellular systems.[2] One of the important features of GHSR1a displays constitutive activity possessing basal activity in the absence of an agonist, resulting in a high degree of receptor internalization as well as of signaling activity.[2] Inverse agonists for the ghrelin receptor could be particularly interesting for the treatment of obesity.[4] This activity seems to provide a tonic signal required for the development of normal height, probably through an effect on the GH axis.[5]
Transcripts[edit]
Two identified transcript variants are expressed in several tissues and are evolutionary conserved in fish and swine. One transcript, 1a, excises an intron and encodes the functional protein; this protein is the receptor for the ghrelin ligand and defines a neuroendocrine pathway for growth hormone release. The second transcript (1b) retains the intron and does not function as a receptor for ghrelin; however, it may function to attenuate activity of isoform 1a.[6]
Selective ligands[edit]
A range of selective ligands for the GHSR receptor are now available and are being developed for several clinical applications. GHSR agonists have appetite-stimulating and growth hormone-releasing effects, and are likely to be useful for the treatment of muscle wasting and frailty associated with old-age and degenerative diseases. On the other hand, GHSR antagonists have anorectic effects and are likely to be useful for the treatment of obesity.
Agonists[edit]
- Capromorelin
- GHRP-2
- GHRP-6
- Hexarelin
- Ipamorelin
- MK-677
- SM-130,686
- Tabimorelin
Antagonists[edit]
References[edit]
- ^ Davenport AP, Bonner TI, Foord SM, Harmar AJ, Neubig RR, Pin JP, Spedding M, Kojima M, Kangawa K (2005). "International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function". Pharmacol. Rev. 57 (4): 541–6. doi:10.1124/pr.57.4.1. PMID 16382107.
- ^ a b c Pazos Y, Casanueva FF, Camiña JP (2007). "Basic aspects of ghrelin action". Vitam. Horm. 77: 89–119. doi:10.1016/S0083-6729(06)77005-4. PMID 17983854.
- ^ Wren AM, Small CJ, Ward HL, et al. (November 2000). "The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion". Endocrinology 141 (11): 4325–8. doi:10.1210/en.141.11.4325. PMID 11089570.
- ^ Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW (2003). "High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist". Mol. Endocrinol. 17 (11): 2201–10. doi:10.1210/me.2003-0069. PMID 12907757.
- ^ Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S (2006). "Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature". J Clin Invest. 116 (3): 760–8. doi:10.1172/JCI25303. PMC 1386106. PMID 16511605.
- ^ "Entrez Gene: GHSR growth hormone secretagogue receptor".
Further reading[edit]
- Smith RG, Leonard R, Bailey AR, et al. (2001). "Growth hormone secretagogue receptor family members and ligands.". Endocrine 14 (1): 9–14. doi:10.1385/ENDO:14:1:009. PMID 11322507.
- Petersenn S (2003). "Structure and regulation of the growth hormone secretagogue receptor.". Minerva Endocrinol. 27 (4): 243–56. PMID 12511847.
- Holst B, Schwartz TW (2006). "Ghrelin receptor mutations--too little height and too much hunger.". J. Clin. Invest. 116 (3): 637–41. doi:10.1172/JCI27999. PMC 1386123. PMID 16511600.
- Nogueiras R, Perez-Tilve D, Wortley KE, Tschöp M (2006). "Growth hormone secretagogue (ghrelin-) receptors--a complex drug target for the regulation of body weight.". CNS & neurological disorders drug targets 5 (3): 335–43. doi:10.2174/187152706777452227. PMID 16787234.
- Engbaek K (1978). "[Giardia lamblia and other intestinal parasites in children in day-institutions. Incidence and significance]". Ugeskr. Laeg. 140 (1): 14–7. PMID 601898.
- Howard AD, Feighner SD, Cully DF, et al. (1996). "A receptor in pituitary and hypothalamus that functions in growth hormone release.". Science 273 (5277): 974–7. doi:10.1126/science.273.5277.974. PMID 8688086.
- McKee KK, Palyha OC, Feighner SD, et al. (1997). "Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.". Mol. Endocrinol. 11 (4): 415–23. doi:10.1210/me.11.4.415. PMID 9092793.
- Kaji H, Tai S, Okimura Y, et al. (1999). "Cloning and characterization of the 5'-flanking region of the human growth hormone secretagogue receptor gene.". J. Biol. Chem. 273 (51): 33885–8. doi:10.1074/jbc.273.51.33885. PMID 9852035.
- Kojima M, Hosoda H, Date Y, et al. (2000). "Ghrelin is a growth-hormone-releasing acylated peptide from stomach.". Nature 402 (6762): 656–60. doi:10.1038/45230. PMID 10604470.
- Deghenghi R, Papotti M, Ghigo E, Muccioli G (2001). "Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland.". J. Endocrinol. Invest. 24 (1): RC1–3. PMID 11227737.
- Tannenbaum GS, Bowers CY (2001). "Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.". Endocrine 14 (1): 21–7. doi:10.1385/ENDO:14:1:021. PMID 11322498.
- Petersenn S, Rasch AC, Penshorn M, et al. (2001). "Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor.". Endocrinology 142 (6): 2649–59. doi:10.1210/en.142.6.2649. PMID 11356716.
- Shuto Y, Shibasaki T, Otagiri A, et al. (2002). "Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity.". J. Clin. Invest. 109 (11): 1429–36. doi:10.1172/JCI13300. PMC 150991. PMID 12045256.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Gaytan F, Barreiro ML, Chopin LK, et al. (2003). "Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary.". J. Clin. Endocrinol. Metab. 88 (2): 879–87. doi:10.1210/jc.2002-021196. PMID 12574228.
- Dass NB, Munonyara M, Bassil AK, et al. (2003). "Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin.". Neuroscience 120 (2): 443–53. doi:10.1016/S0306-4522(03)00327-0. PMID 12890514.
- Lall S, Balthasar N, Carmignac D, et al. (2004). "Physiological studies of transgenic mice overexpressing growth hormone (GH) secretagogue receptor 1A in GH-releasing hormone neurons.". Endocrinology 145 (4): 1602–11. doi:10.1210/en.2003-1509. PMID 14701677.
- Wang HJ, Geller F, Dempfle A, et al. (2004). "Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature.". J. Clin. Endocrinol. Metab. 89 (1): 157–62. doi:10.1210/jc.2003-031395. PMID 14715843.
External links[edit]
- "Ghrelin Receptor". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
- growth hormone secretagogue receptor at the US National Library of Medicine Medical Subject Headings (MeSH)
- Ghrelin at Colorado State University
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Cell surface receptor: G protein-coupled receptors
|
|
Class A:
Rhodopsin like |
|
|
Class B: Secretin like |
Orphan
|
- GPR (56
- 64
- 97
- 98
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 123
- 124
- 125
- 126
- 128
- 133
- 143
- 144
- 155
- 157)
|
|
Other
|
- Brain-specific angiogenesis inhibitor (1
- 2
- 3)
- Cadherin (1
- 2
- 3)
- Calcitonin
- CALCRL
- CD97
- Corticotropin-releasing hormone (1
- 2)
- EMR (1
- 2
- 3)
- Glucagon (GR
- GIPR
- GLP1R
- GLP2R)
- Growth hormone releasing hormone
- PACAPR1
- GPR
- Latrophilin (1
- 2
- 3
- ELTD1)
- Methuselah-like proteins
- Parathyroid hormone (1
- 2)
- Secretin
- Vasoactive intestinal peptide (1
- 2)
|
|
|
Class C: Metabotropic
glutamate / pheromone |
Taste
|
- TAS1R (1
- 2
- 3)
- TAS2R (1
- 3
- 4
- 5
- 7
- 8
- 9
- 10
- 13
- 14
- 16
- 19
- 20
- 30
- 31
- 38
- 39
- 40
- 41
- 42
- 43
- 45
- 46
- 50
- 60)
|
|
Other
|
- Calcium-sensing receptor
- GABA B (1
- 2)
- Glutamate receptor (Metabotropic glutamate (1
- 2
- 3
- 4
- 5
- 6
- 7
- 8))
- GPRC6A
- GPR (156
- 158
- 179)
- RAIG (1
- 2
- 3
- 4)
|
|
|
Class F:
Frizzled / Smoothened |
Frizzled
|
- Frizzled (1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10)
|
|
Smoothened
|
|
|
|
B trdu: iter (nrpl/grfl/cytl/horl), csrc (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd; path (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
|
|
Neuropeptidergics
|
|
Cholecystokinin |
CCKA
|
- Agonists: Cholecystokinin
- CCK-4
Antagonists: Asperlicin
- Proglumide
- Lorglumide
- Devazepide
- Dexloxiglumide
|
|
CCKB
|
- Agonists: Cholecystokinin
- CCK-4
- Gastrin
Antagonists: Proglumide
- CI-988
|
|
|
CRH |
CRF1
|
- Agonists: Corticotropin releasing hormone
Antagonists: Antalarmin
- CP-154,526
- Pexacerfont
|
|
CRF2
|
- Agonists: Corticotropin releasing hormone
|
|
|
Galanin |
GAL1
|
- Agonists: Galanin
- Galanin-like peptide
- Galmic
- Galnon
|
|
GAL2
|
- Agonists: Galanin
- Galanin-like peptide
- Galmic
- Galnon
|
|
GAL3
|
- Agonists: Galanin
- Galmic
- Galnon
|
|
|
Ghrelin |
- Agonists: Ghrelin
- Capromorelin
- MK-677
- Sermorelin
- SM-130,686
- Tabimorelin
|
|
GnRH |
- Agonists: Buserelin
- Deslorelin
- GnRH
- Goserelin
- Histrelin
- Leuprorelin
- Nafarelin
- Triptorelin
Antagonists: Abarelix
- Cetrorelix
- Degarelix
- Ganirelix
|
|
MCH |
MCH1
|
- Agonists: Melanin concentrating hormone
Antagonists: ATC-0175
- GW-803,430
- NGD-4715
- SNAP-7941
- SNAP-94847
|
|
MCH2
|
- Agonists: Melanin concentrating hormone
|
|
|
Melanocortin |
MC1
|
- Agonists: alpha-MSH
- Afamelanotide
- BMS-470,539
- Bremelanotide
- Melanotan II
Antagonists: Agouti signalling peptide
|
|
MC2
|
- Agonists: ACTH
- Cosyntropin
- Tetracosactide
|
|
MC3
|
- Agonists: alpha-MSH
- Bremelanotide
- Melanotan II
|
|
MC4
|
- Agonists: alpha-MSH
- Bremelanotide
- Melanotan II
- PF-00446687
- THIQ
Antagonists: Agouti-related peptide
|
|
MC5
|
- Agonists: alpha-MSH
- Melanotan II
|
|
|
Neuropeptide S |
- Agonists: Neuropeptide S
Antagonists: SHA-68
|
|
Neuropeptide Y |
Y1
|
- Agonists: Neuropeptide Y
- Peptide YY
Antagonists: BIBP-3226
|
|
Y2
|
- Agonists: Neuropeptide Y
- Peptide YY
Antagonists: BIIE-0246
|
|
Y4
|
- Agonists: Neuropeptide Y
- Pancreatic polypeptide
- Peptide YY
Antagonists: UR-AK49
|
|
Y5
|
- Agonists: Neuropeptide Y
- Peptide YY
Antagonists: Lu AA-33810
|
|
|
Neurotensin |
NTS1
|
- Agonists: Neurotensin
- Neuromedin N
Antagonists: SR-48692
- SR-142,948
|
|
NTS2
|
- Agonists: Neurotensin
Antagonists: Levocabastine
- SR-142,948
|
|
|
Orexin |
OX1
|
- Agonists: Orexin-A
Antagonists: Almorexant
- SB-334,867
- SB-408,124
- SB-649,868
- Suvorexant
|
|
OX2
|
- Agonists: Orexin-A
Antagonists: Almorexant
- SB-649,868
- Suvorexant
- TCS-OX2-29
|
|
|
Oxytocin |
- Agonists: Carbetocin
- Demoxytocin
- Oxytocin
- WAY-267,464
Antagonists: Atosiban
- Epelsiban
- L-371,257
- L-368,899
- Retosiban
|
|
Tachykinin |
NK1
|
- Agonists: Substance P
Antagonists: Aprepitant
- Befetupitant
- Casopitant
- CI-1021
- CP-96,345
- CP-99,994
- CP-122,721
- Dapitant
- Ezlopitant
- FK-888
- Fosaprepitant
- GR-203,040
- GW-597,599
- HSP-117
- L-733,060
- L-741,671
- L-743,310
- L-758,298
- Lanepitant
- LY-306,740
- Maropitant
- Netupitant
- NKP-608
- Nolpitantium
- Orvepitant
- RP-67,580
- SDZ NKT 343
- Vestipitant
- Vofopitant
|
|
NK2
|
- Agonists: Neurokinin A
Antagonists: GR-159,897
- Ibodutant
- Saredutant
|
|
NK3
|
- Agonists: Neurokinin B
Antagonists: Osanetant
- Talnetant
|
|
|
Vasopressin |
V1A
|
- Agonists: Desmopressin
- Felypressin
- Ornipressin
- Terlipressin
- Vasopressin
Antagonists: Conivaptan
- Demeclocycline
- Relcovaptan
|
|
V1B
|
- Agonists: Felypressin
- Ornipressin
- Terlipressin
- Vasopressin
Antagonists: Demeclocycline
- Nelivaptan
|
|
V2
|
- Agonists: Desmopressin
- Ornipressin
- Vasopressin
Antagonists: Conivaptan
- Demeclocycline
- Lixivaptan
- Mozavaptan
- Satavaptan
- Tolvaptan
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Food restriction, ghrelin, its antagonist and obestatin control expression of ghrelin and its receptor in chicken hypothalamus and ovary.
- Sirotkin AV, Pavlova S, Tena-Sempere M, Grossmann R, Jiménez MR, Rodriguez JM, Valenzuela F.SourceDept. Genetics and Reproduction, Research Centre of Animal Production, Hlohovecká 2, 949 92 Luzianky, Slovakia; Dept. Zoology and Anthropology, Constantine the Philosopher University, 949 74 Nitra, Slovakia. Electronic address: sirotkin@cvzv.sk.
- Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.Comp Biochem Physiol A Mol Integr Physiol.2013 Jan;164(1):141-53. doi: 10.1016/j.cbpa.2012.07.010. Epub 2012 Aug 1.
- The purpose of the present study was to identify the role of age, nutritional state and some metabolic hormones in control of avian hypothalamic and ovarian ghrelin/ghrelin receptor system. We examined the effect of food restriction, administration of ghrelin 1-18, ghrelin antagonistic analogue (D-L
- PMID 22877785
- Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points.
- Söderpalm B, Ericson M.SourceAddiction Biology Unit, Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. bo.soderpalm@neuro.gu.se
- Current topics in behavioral neurosciences.Curr Top Behav Neurosci.2013;13:127-61. doi: 10.1007/7854_2011_170.
- The brain reward system, and especially the mesolimbic dopamine pathway, plays a major role in drug reinforcement and is most likely involved in the development of drug addiction. All major drugs of abuse, including ethanol, acutely activate the mesolimbic dopamine system. Both this acute drug-induc
- PMID 22094880
Japanese Journal
- グレリン受容体 : リガンド非依存性の恒常的活性化とその異常 (第5土曜特集 GPCR研究の最前線2016) -- (GPCR機能の新展開)
- Effects of retinoic acid on growth hormone-releasing hormone receptor, growth hormone secretagogue receptor gene expression and growth hormone secretion in rat anterior pituitary cells
- Effects of retinoic acid on growth hormone-releasing hormone receptor, growth hormone secretagogue receptor gene expression and growth hormone secretion in rat anterior pituitary cells
Related Links
- Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn). ... The ghrelin receptor (nomenclature as agreed by the NC-IUPHAR Subcommittee for ...
- Ghrelin is a 28 amino acid peptide that is the natural ligand for the growth hormone secretagogue receptor (GHS-R). Based on its structure, it is a member of the motilin family of peptides. When administered peripherally or into the ...
★リンクテーブル★
[★]
- 英
- ghrelin receptor
- 関
- グレリンレセプター
[★]
- 英
- ghrelin receptor
- 関
- グレリン受容体